findmyKOL

Kevin Greenidge, MD

Basic profile

SUNY Downstate Health Sciences University

ORCIDNone on fileNPI
RegionWebster, TX · South CentralSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2006Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Kevin Greenidge is an Ophthalmology physician affiliated with SUNY Downstate Health Sciences University. OpenAlex indexes 25 publications with 540 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
25publications

Distinct works indexed by OpenAlex.

540citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

200 Blossom St
Webster, TX 775984204

Telephone

409-772-5800

Provider last certified this registry record 20 Mar 2023.

View the NPPES registry record

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    93.3%
    Carbonic Anhydrase Inhibitor37.8%
    Dorzolamide-Timolol59%Dorzolamide Hcl26%Simbrinza15%
    Part D<11 patients
    Prostaglandin Analog34.2%
    Latanoprost100%
    Part D31 patients

    + 2 more classes in this area

  • Cardiovascular

    6.7%
    Beta blocker6.7%
    Timolol Maleate100%
    Part D<11 patients
Where care is delivered (Part B)3.5% facility · 96.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

  • Central Corneal Thickness and Argon Laser Trabeculoplasty Outcomes in African Americans with Primary Open Angle Glaucoma

    Investigative Ophthalmology & Visual Science

    2006
  • Decreased Ocular Blood Flow in Patients with Advanced Optic Nerve Cupping
    2006
  • Race, politics, ethnicity, and science

    American Journal of Ophthalmology

    2005
  • Relation Between Acknowledged Glaucoma Risk Factors and Abnormal FDT Field Tests in Population–Based Glaucoma Screening

    Investigative Ophthalmology & Visual Science

    2005
  • Increased Heterogeneity in Retinal Blood Flow of Glaucoma Patients
    2005
19 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”